181 related articles for article (PubMed ID: 25517272)
21. Incidence of contrast-induced nephropathy in hospitalised patients with cancer.
Cicin I; Erdogan B; Gulsen E; Uzunoglu S; Sut N; Turkmen E; Kodaz H; Ustundag S
Eur Radiol; 2014 Jan; 24(1):184-90. PubMed ID: 24220752
[TBL] [Abstract][Full Text] [Related]
22. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
Feldkamp T; Kribben A
Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
[TBL] [Abstract][Full Text] [Related]
23. Prospective study of the incidence of contrast-induced nephropathy among patients evaluated for pulmonary embolism by contrast-enhanced computed tomography.
Mitchell AM; Jones AE; Tumlin JA; Kline JA
Acad Emerg Med; 2012 Jun; 19(6):618-25. PubMed ID: 22687176
[TBL] [Abstract][Full Text] [Related]
24. Influence of Clinical Factors on Risk of Contrast-Induced Nephrotoxicity From IV Iodinated Low-Osmolality Contrast Material in Patients With a Low Estimated Glomerular Filtration Rate.
Ellis JH; Khalatbari S; Yosef M; Cohan RH; Davenport MS
AJR Am J Roentgenol; 2019 Nov; 213(5):W188-W193. PubMed ID: 31268731
[No Abstract] [Full Text] [Related]
25. The clinical and renal consequences of contrast-induced nephropathy.
Finn WF
Nephrol Dial Transplant; 2006 Jun; 21(6):i2-10. PubMed ID: 16723349
[TBL] [Abstract][Full Text] [Related]
26. Contribution of platelets indices in the development of contrast-induced nephropathy.
Sahin I; Karabulut A; Avci II; Okuyan E; Biter HI; Yildiz SS; Can MM; Gungor B; Dinckal M; Serebruany V
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):246-9. PubMed ID: 24695089
[TBL] [Abstract][Full Text] [Related]
27. Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting.
Mitchell AM; Jones AE; Tumlin JA; Kline JA
Clin J Am Soc Nephrol; 2010 Jan; 5(1):4-9. PubMed ID: 19965528
[TBL] [Abstract][Full Text] [Related]
28. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.
Iakovou I; Dangas G; Mehran R; Lansky AJ; Ashby DT; Fahy M; Mintz GS; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
J Invasive Cardiol; 2003 Jan; 15(1):18-22. PubMed ID: 12499523
[TBL] [Abstract][Full Text] [Related]
29. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
Fishman EK; Reddan D
Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
[TBL] [Abstract][Full Text] [Related]
30. Contrast-induced nephropathy--prevention and risk reduction.
Lameire NH
Nephrol Dial Transplant; 2006 Jun; 21(6):i11-23. PubMed ID: 16723348
[TBL] [Abstract][Full Text] [Related]
31. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
Schönefeld E; Höwler S; Osada N; Torsello G
Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540
[TBL] [Abstract][Full Text] [Related]
32. Contrast-induced nephropathy in patients with active cancer undergoing contrast-enhanced computed tomography.
Hong SI; Ahn S; Lee YS; Kim WY; Lim KS; Lee JH; Lee JL
Support Care Cancer; 2016 Mar; 24(3):1011-7. PubMed ID: 26238629
[TBL] [Abstract][Full Text] [Related]
33. Contrast induced nephropathy in diabetic and non-diabetic patients during coronary angiogram and angioplasty.
Rahman MM; Haque HS; Banerjee SK; Ahsan SA; Rahman MF; Mahmood M; Salman M; Azam MG
Mymensingh Med J; 2010 Jul; 19(3):372-6. PubMed ID: 20639829
[TBL] [Abstract][Full Text] [Related]
34. Defining incidence and outcome of contrast-induced nephropathy among trauma: is it overhyped?
Kulvatunyou N; Rhee PM; Carter SN; Roberts PM; Lees JS; Bender JS; Albrecht RM
Am Surg; 2011 Jun; 77(6):686-9. PubMed ID: 21679633
[TBL] [Abstract][Full Text] [Related]
35. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
[TBL] [Abstract][Full Text] [Related]
36. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
[TBL] [Abstract][Full Text] [Related]
37. Patients at risk for contrast-induced nephropathy and mid-term effects after contrast administration: a prospective cohort study.
Moos SI; Nagan G; de Weijert RS; van Vemde DN; Stoker J; Bipat S
Neth J Med; 2014 Sep; 72(7):363-71. PubMed ID: 25178770
[TBL] [Abstract][Full Text] [Related]
38. Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease.
Sigterman TA; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GW; Bouwman LH
Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):386-93. PubMed ID: 26460289
[TBL] [Abstract][Full Text] [Related]
39. Risk for contrast-induced nephropathy in elderly trauma patients.
Finigan R; Pham J; Mendoza R; Lekawa M; Dolich M; Kong A; Bernal N; Lush S; Barrios C
Am Surg; 2012 Oct; 78(10):1114-7. PubMed ID: 23025953
[TBL] [Abstract][Full Text] [Related]
40. Risk of contrast-induced nephropathy in patients undergoing endovascular treatment of acute ischemic stroke.
Sharma J; Nanda A; Jung RS; Mehta S; Pooria J; Hsu DP
J Neurointerv Surg; 2013 Nov; 5(6):543-5. PubMed ID: 23125428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
